Prevention of thrombosis

Transcription

1 Prevention of thrombosis Massimo Lamperti MD, MBA Chief of General Anaesthesia Department Anaesthesiology Institute Cleveland Clinic Abu Dhabi Clinical Professor of Anaesthesiology Cleveland Clinic Lerner College of Medicine of Case Western Reserve

2

3 Disclosures Member of the Cochrane Review for A&E and Critical Care Advisor for Masimo, Draeger 3

4 Topics of this presentation Thrombosis: location, diagnosis, treatment Literature Prevention: SDI 4

5 Catheter-related thrombosis: location Upper body Lower body Location of thrombus: 5

6 Catheter-related thrombosis: Diagnosis Compressive ultrasound Doppler ultrasound Phlebography CT angio 6

7 Catheter-related thrombosis: Diagnosis/Treatment 7

8 Catheter-related thrombosis: Treatment Use of anticoagulant treatment for routine prophylaxis of CRT is not recommended A CVC should be inserted on the right side, in the IJV, and the distal tip of the CVC should be located at the junction of the superior vena cava and the right atrium 8

9 Catheter-related thrombosis: Treatment 9

10 Catheter-related thrombosis: Treatment 10

11 Literature Big biases for heterogeneity and selection Related more on DVT(5-29%) than asymptomatic thrombosis (40-66%) Higher risk in ICU? oncological patients? 11

12 12

13 A 1-year prospective observational study of PICC insertions was conducted A total of 2014 PICCs for a total of days of PICC placement 57 pts PICC associated DVT 11 pts pulmonary embolism Chest 2010;138(4):

14 21 putative risk factors for DVT were examined: PICC size, length duration final tip location reason for PICC insertion accessed arm and vein patient sex and age insertion nurse insertion division previous DVT previous cancer hypercoagulability surgery duration>1 h bed rest; BMI 29 kg/m2 receiving hormone replacement or oral contraception admission diagnosis use of anticoagulants use of pressors Chest 2010;138(4):

15 DVT 3% Chest 2010;138(4):

16 A 3-year, prospective, observational study of all PICC insertions by a specially trained a CHEST 2013; 143(3):

17 DVT from 3% (2008) to 1.9% (2010) Cost and LOS attributable to PICC-associated DVT were $15973 and 4.6 days CHEST 2013; 143(3):

18 18

19 19

20 20

21 21

22 22

23 Prospective study performed on a large cohort (n = 400) of patients with cancer aged >18 requiring long-term CVC implantation for chemotherapy infusion Patients underwent ultrasound examination at 1 and 6 months after CVC implantation to detect 'early' (1 month) and 'late' (6 months) asymptomatic DVT or fibrin sheaths incidence. Sixty-nine patients underwent US examination also 12 months after CVC implantation Incidence of CVC-related thrombosis was 0.10 events per 1000 catheter days. Anticoagulation therapy with LWMH resolved 50% of DVT, but no CVC needed removing. Incidence of new onset fibrin sheaths was 0.71 events per 1000 catheter days. Fibrin sheaths resolution occurred independently of LWMH therapy. 23

24 retrospective study on 89 patients ICU patients average indwelling times: 22±12 days one episode of symptomatic thrombosis 8 cases of partial obstruction solved with NS flush 24

25 Catheter-related thrombosis: prevention S: Selection D: Detection I: Intervention 25

26 Selection of the vein and catheter Catheter-related thrombosis due to incorrect catheter/vein Nifong et al., Chest

27 Selection of the vein and catheter Prospective cohort; n=136, 1 site, Australia Association between catheter#vein#vte Patients with a C:V ratio > 45% RR 13.0 ( ) for DVT compared to those <45% (adjusted for co-morbidities, meds) Sharp R, et al. Int J Nursing Studies

28 Detection Incidence of internal jugular vein CRT was 26.7%, corresponding to 70.5 cases per 1,000 catheter days. Incidence of "fibrin sleeve" was 28.4% Incidence of CRT was not associated with duration of the placement of the introducer catheter (average 3.9±2 days) or the SGC (average of 2.4±1.7 days Infusion of total parenteral nutrition and dextran showed a significantly increased risk of thrombosis 28

29 Intervention Lock of the catheter 29

30 Intervention HS is not superior to NS in reducing CVCs occlusion In the short term, the use of HS is slightly superior to NS for flushing catheters from a statistical point of view 30

31 Keynotes Selection of catheter and vein is the key Big heterogeneity in the definition of catheterrelated thrombosis Use of a bundle can help reducing the risk of thrombosis 31

32 The risk exists if we don t prevent 32

33 33

34 For any questions or if you want a copy of these slides: LamperM@clevelandclinicabudhabi.ae